R. Mayeux, L. Honig, M. Tang, J. Manly, Y. Stern et al., Plasma A??40 and A??42 and Alzheimer's disease: Relation to age, mortality, and risk, Neurology, vol.61, issue.9, pp.1185-90, 2003.
DOI : 10.1212/01.WNL.0000091890.32140.8F

M. Van-oijen, A. Hofman, H. Soares, P. Koudstaal, and M. Breteler, Plasma A??1???40 and A??1???42 and the risk of dementia: a prospective case-cohort study, The Lancet Neurology, vol.5, issue.8, pp.655-60, 2006.
DOI : 10.1016/S1474-4422(06)70501-4

J. Lambert, S. Schraen-maschke, F. Richard, N. Fievet, O. Rouaud et al., Association of plasma amyloid ?? with risk of dementia: The prospective Three-City Study, Neurology, vol.73, issue.11, pp.847-53, 2009.
DOI : 10.1212/WNL.0b013e3181b78448

T. Seppala, S. Herukka, T. Hanninen, S. Tervo, M. Hallikainen et al., Plasma Abeta42 and Abeta40 as markers of cognitive change in follow-up: a prospective, longitudinal, population-based cohort study, Journal of neurology, vol.81, issue.10, pp.1123-1130, 2010.

J. Lui, S. Laws, Q. Li, V. Villemagne, D. Ames et al., Plasma Amyloid-?? as a Biomarker in Alzheimer's Disease: The AIBL Study of Aging, Journal of Alzheimer's Disease, vol.20, issue.4, pp.1233-1275, 2010.
DOI : 10.3233/JAD-2010-090249

K. Yaffe, A. Weston, N. Graff-radford, S. Satterfield, E. Simonsick et al., Association of Plasma ??-Amyloid Level and Cognitive Reserve With Subsequent Cognitive Decline, JAMA, vol.305, issue.3, pp.261-267, 2011.
DOI : 10.1001/jama.2010.1995

A. Gabelle, F. Richard, L. Gutierrez, S. Schraen, F. Delva et al., Plasma Amyloid-beta Levels and Prognosis in Incident Dementia Cases of the 3-City Study, Journal of Alzheimer

M. Hernandez-guillamon, P. Delgado, A. Penalba, D. Rodriguez-luna, C. Molina et al., Plasma beta-amyloid levels in cerebral amyloid angiopathyassociated hemorrhagic stroke, Neuro-degenerative diseases, vol.10, pp.1-4320, 2012.

B. Dubois, H. Feldman, C. Jacova, J. Cummings, S. Dekosky et al., Revising the definition of Alzheimer's disease: a new lexicon, The Lancet Neurology, vol.9, issue.11, pp.1118-1145, 2010.
DOI : 10.1016/S1474-4422(10)70223-4

C. Jack, J. Knopman, D. Jagust, W. Shaw, L. Aisen et al., Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade, The Lancet Neurology, vol.9, issue.1, pp.119-147, 2010.
DOI : 10.1016/S1474-4422(09)70299-6

C. Smith and D. Betteridge, Plasma ??-amyloid (A??) 40 concentration, lipid status and age in humans, Neuroscience Letters, vol.367, issue.1, pp.48-50, 2004.
DOI : 10.1016/j.neulet.2004.05.081

H. Fukumoto, M. Tennis, J. Locascio, B. Hyman, J. Growdon et al., Age but Not Diagnosis Is the Main Predictor of Plasma Amyloid ??-Protein Levels, Archives of Neurology, vol.60, issue.7, pp.958-64, 2003.
DOI : 10.1001/archneur.60.7.958

A. Metti, J. Cauley, H. Ayonayon, T. Harris, C. Rosano et al., The Demographic and Medical Correlates of Plasma Abeta40 and Abeta42. Alzheimer disease and associated disorders, 2012.

J. Lambert, J. Dallongeville, K. Ellis, S. Schraen-maschke, J. Lui et al., Association of Plasma A?? Peptides with Blood Pressure in the Elderly, PLoS ONE, vol.66, issue.4, p.18536, 2011.
DOI : 10.1371/journal.pone.0018536.s002

A. Metti, J. Cauley, A. Newman, H. Ayonayon, L. Barry et al., Plasma Beta Amyloid Level and Depression in Older Adults. The journals of gerontology. Series A, Biological sciences and medical sciences, 2012.

N. Fujimoto, N. Wada, M. Akiyama, S. Tajima, A. Ishibashi et al., Coexistence of beta2 microglobulin and lambda light chain in amyloid fibrils of dialysis-unrelated plasma cell dyscrasia-associated systemic amyloidosis, British Journal of Dermatology, vol.14, issue.3, pp.549-53, 2002.
DOI : 10.1021/bi9530550

T. Drueke, Beta2-microglobulin and amyloidosis. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association -European Renal Association, pp.17-24, 2000.

S. Debette, J. Lambert, J. Gariepy, N. Fievet, C. Tzourio et al., New Insight Into the Association of Apolipoprotein E Genetic Variants With Carotid Plaques and Intima-Media Thickness, Stroke, vol.37, issue.12, pp.2917-2940, 2006.
DOI : 10.1161/01.STR.0000249011.94055.00

T. Kokjohn, V. Vickle, G. Maarouf, C. Kalback, W. Hunter et al., Chemical characterization of pro-inflammatory amyloid-beta peptides in human atherosclerotic lesions and platelets, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol.1812, issue.11, pp.1508-1522, 2011.
DOI : 10.1016/j.bbadis.2011.07.004

M. Gomis, T. Sobrino, A. Ois, M. Millan, A. Rodriguez-campello et al., Plasma ??-Amyloid 1-40 Is Associated With the Diffuse Small Vessel Disease Subtype, Stroke, vol.40, issue.10, pp.3197-201, 2009.
DOI : 10.1161/STROKEAHA.109.559641

A. Warfel, D. Zucker-franklin, B. Frangione, and J. Ghiso, Constitutive secretion of cystatin C (gamma-trace) by monocytes and macrophages and its downregulation after stimulation, Journal of Experimental Medicine, vol.166, issue.6, pp.1912-1919, 1987.
DOI : 10.1084/jem.166.6.1912

G. Filler, A. Bokenkamp, W. Hofmann, L. Bricon, T. Martinez-bru et al., Cystatin C as a marker of GFR???history, indications, and future research, Clinical Biochemistry, vol.38, issue.1, pp.1-8, 2005.
DOI : 10.1016/j.clinbiochem.2004.09.025

J. Sundelof, J. Arnlov, E. Ingelsson, J. Sundstrom, S. Basu et al., Serum cystatin C and the risk of Alzheimer disease in elderly men, Neurology, vol.71, issue.14, pp.1072-1081, 2008.
DOI : 10.1212/01.wnl.0000326894.40353.93

W. Mi, S. Jung, H. Yu, S. Schmidt, R. Nixon et al., Complexes of Amyloid-?? and Cystatin C in the Human Central Nervous System, Journal of Alzheimer's Disease, vol.18, issue.2, pp.273-80, 2009.
DOI : 10.3233/JAD-2009-1147

M. Sastre, M. Calero, M. Pawlik, P. Mathews, A. Kumar et al., Binding of cystatin C to Alzheimer???s amyloid ?? inhibits in vitro amyloid fibril formation, Neurobiology of Aging, vol.25, issue.8, pp.1033-1076, 2004.
DOI : 10.1016/j.neurobiolaging.2003.11.006

K. Maruyama, S. Ikeda, T. Ishihara, D. Allsop, and N. Yanagisawa, Immunohistochemical characterization of cerebrovascular amyloid in 46 autopsied cases using antibodies to beta protein and cystatin C, Stroke, vol.21, issue.3, pp.397-403, 1990.
DOI : 10.1161/01.STR.21.3.397

M. Selenica, X. Wang, L. Ostergaard-pedersen, A. Westlind-danielsson, and A. Grubb, formation of soluble A??1???42 oligomers and protofibrils, Scandinavian Journal of Clinical and Laboratory Investigation, vol.19, issue.2, pp.179-90, 2007.
DOI : 10.1007/BF00291159

S. Kaeser, M. Herzig, J. Coomaraswamy, E. Kilger, M. Selenica et al., Cystatin C modulates cerebral ??-amyloidosis, Nature Genetics, vol.8, issue.12, pp.1437-1446, 2007.
DOI : 10.1016/j.clinbiochem.2004.09.025

J. Toledo, H. Vanderstichele, M. Figurski, P. Aisen, R. Petersen et al., Factors affecting A?? plasma levels and their utility as biomarkers in ADNI, Acta Neuropathologica, vol.305, issue.3, pp.401-414, 2011.
DOI : 10.1007/s00401-011-0861-8

L. Bastard, N. Leurs, J. Blomme, W. De, D. Pp et al., Plasma Amyloidbeta Forms in Alzheimer's Disease and Non-Alzheimer's Disease Patients, J Alzheimers Dis, 2010.

J. Lui, S. Laws, Q. Li, V. Villemagne, D. Ames et al., Plasma Amyloid-beta as a Biomarker in Alzheimer's Disease: The AIBL Study of Aging, J Alzheimers Dis, 2010.

J. Dumurgier, C. Paquet, S. Benisty, C. Kiffel, C. Lidy et al., Inverse association between CSF A?? 42 levels and years of education in mild form of Alzheimer's disease: The cognitive reserve theory, Neurobiology of Disease, vol.40, issue.2, pp.456-465, 2010.
DOI : 10.1016/j.nbd.2010.07.007

P. Sjogren, W. Becker, E. Warensjo, E. Olsson, L. Byberg et al., Mediterranean and carbohydrate-restricted diets and mortality among elderly men: a cohort study in Sweden, American Journal of Clinical Nutrition, vol.92, issue.4, pp.967-74, 2010.
DOI : 10.3945/ajcn.2010.29345

E. De-hollander, M. Van-zutphen, R. Bogers, W. Bemelmans, D. Groot et al., The impact of body mass index in old age on cause-specific mortality. The journal of nutrition, health & aging, vol.16, issue.1, pp.100-106, 2012.

H. Svendsen and J. Mosbech, Mortality of alcoholic liver cirrhosis Diagnostic background for statistics concerning cause of death], Ugeskrift for laeger, vol.138, issue.31, pp.1910-1921, 1976.

Z. Arvanitakis, J. Lucas, L. Younkin, S. Younkin, and N. Graff-radford, Serum Creatinine Levels Correlate With Plasma Amyloid ?? Protein, Alzheimer Disease & Associated Disorders, vol.16, issue.3, pp.187-90, 2002.
DOI : 10.1097/00002093-200207000-00009

J. Lambert, data acquisition; study supervision; drafting/revising the manuscript

C. Berr, data acquisition; analysis and interpretation of the data; statistical analysis; study concept; study supervision; drafting/revising the manuscript